Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma

[11] Poultsides GA(2014)Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma Journal of Hepatology 60 1268-1289

[12] Zhu AX(2001)Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg. 234 507-17

[13] Choti MA(2016)Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone Cancer. 122 758-65

[14] Pawlik TM(2002)Improved survival in resected biliary malignancies Surgery. 132 555-63

[15] Cillo U(2014)Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis J Surg Oncol. 110 163-70

[16] Spolverato G(2016)The relative effect of hospital and surgeon volume on failure to rescue among patients undergoing liver resection for cancer Surgery. 159 1004-12

[17] Vitale A(2018)Assessment and optimization of liver volume before major hepatic resection: Current guidelines and a narrative review Int J Surg. 52 74-81

[18] Ejaz A(2015)Defining Post Hepatectomy Liver Insufficiency: Where do We stand? J Gastrointest Surg. 19 2079-92

[19] Lonardi S(2012)Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues Oncologist. 17 1504-7

[20] Cosgrove D(2012)Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis J Clin Oncol. 30 1934-40

[11] Poultsides GA(2014)Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma Journal of Hepatology 60 1268-1289

[12] Zhu AX(2001)Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma Ann Surg. 234 507-17

[13] Choti MA(2016)Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone Cancer. 122 758-65

[14] Pawlik TM(2002)Improved survival in resected biliary malignancies Surgery. 132 555-63

[15] Cillo U(2014)Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis J Surg Oncol. 110 163-70

[16] Spolverato G(2016)The relative effect of hospital and surgeon volume on failure to rescue among patients undergoing liver resection for cancer Surgery. 159 1004-12

[17] Vitale A(2018)Assessment and optimization of liver volume before major hepatic resection: Current guidelines and a narrative review Int J Surg. 52 74-81

[18] Ejaz A(2015)Defining Post Hepatectomy Liver Insufficiency: Where do We stand? J Gastrointest Surg. 19 2079-92

[19] Lonardi S(2012)Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues Oncologist. 17 1504-7

[20] Cosgrove D(2012)Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis J Clin Oncol. 30 1934-40